AYTU BIOPHARMA, INC Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q2 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Aytu Biopharma, Inc quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q2 2020 to Q2 2024.
- Aytu Biopharma, Inc Deferred Tax Assets, Net of Valuation Allowance for the quarter ending June 30, 2024 was $762K, a 44.7% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)